{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:16:42Z","timestamp":1789906602705,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX10302206"],"award-info":[{"award-number":["2018ZX10302206"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.amjms.2020.06.023","type":"journal-article","created":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T01:28:26Z","timestamp":1593307706000},"page":"656-661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["High Expression of Interleukin-33\/ST2 Predicts the Progression and Poor Prognosis in Chronic Hepatitis B Patients with Hepatic Flare"],"prefix":"10.1016","volume":"360","author":[{"given":"Wei","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-guo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-ping","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-zhou","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.amjms.2020.06.023_bib0001","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global Epidemiology of Hepatitis B Virus Infection: New Estimates of Age-Specific HBsAg Seroprevalence and Endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.amjms.2020.06.023_bib0002","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1476-0711-4-13","article-title":"Natural History and Treatment of Hepatitis B Virus and Hepatitis C Virus Coinfection","volume":"4","author":"Crockett","year":"2005","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"4","key":"10.1016\/j.amjms.2020.06.023_bib0003","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The Contributions of Hepatitis B Virus and Hepatitis C Virus Infections to Cirrhosis and Primary Liver Cancer Worldwide","volume":"45","author":"Perz","year":"2006","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.amjms.2020.06.023_bib0004","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1136\/gutjnl-2011-301073","article-title":"Innate and Adaptive Immune Responses in Chronic Hepatitis B Virus Infections: Towards Restoration of Immune Control of Viral Infection","volume":"61","author":"Bertoletti","year":"2012","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.amjms.2020.06.023_bib0005","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.immuni.2015.06.006","article-title":"Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation","volume":"42","author":"Molofsky","year":"2015","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.amjms.2020.06.023_bib0006","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1073\/pnas.1201042109","article-title":"Contribution of IL-33-Activated Type II Innate Lymphoid Cells to Pulmonary Eosinophilia in Intestinal Nematode-Infected Mice","volume":"109","author":"Yasuda","year":"2012","journal-title":"Proc Natl Acad Sci U.S.A."},{"issue":"1","key":"10.1016\/j.amjms.2020.06.023_bib0007","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.0606854104","article-title":"IL-33, the IL-1-Like Cytokine Ligand for ST2 Receptor, is a Chromatin-Associated Nuclear Factor in Vivo","volume":"104","author":"Carriere","year":"2007","journal-title":"Proc Natl Acad Sci U.S.A."},{"issue":"2","key":"10.1016\/j.amjms.2020.06.023_bib0008","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4161\/onci.1.2.18131","article-title":"IL-33\/ST2 Axis in Innate and Acquired Immunity to Tumors","volume":"1","author":"Jovanovic","year":"2012","journal-title":"Oncoimmunology"},{"issue":"1\u20132","key":"10.1016\/j.amjms.2020.06.023_bib0009","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12026-012-8283-9","article-title":"IL-33\/ST2 Axis in Inflammation and Immunopathology","volume":"52","author":"Milovanovic","year":"2012","journal-title":"Immunol Res"},{"issue":"6B","key":"10.1016\/j.amjms.2020.06.023_bib0010","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1111\/j.1582-4934.2009.00801.x","article-title":"Interleukin-33 Overexpression is Associated with Liver Fibrosis in Mice and Humans","volume":"14","author":"Marvie","year":"2010","journal-title":"J Cell Mol Med"},{"issue":"10","key":"10.1016\/j.amjms.2020.06.023_bib0011","doi-asserted-by":"crossref","first-page":"e3331","DOI":"10.1371\/journal.pone.0003331","article-title":"The IL-1-Like Cytokine IL-33 is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells in Vivo: A Novel \u2018Alarmin\u2019?","volume":"3","author":"Moussion","year":"2008","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.amjms.2020.06.023_bib0012","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/IAI.02908-14","article-title":"Crucial and diverse role of the interleukin-33\/ST2 axis in infectious diseases","volume":"83","author":"Rostan","year":"2015","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.amjms.2020.06.023_bib0013","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.1206587110","article-title":"IL-33 Drives Biphasic IL-13 Production for Noncanonical Type 2 Immunity Against Hookworms","volume":"110","author":"Hung","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.amjms.2020.06.023_bib0014","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1177\/030006051204000504","article-title":"Detection of Interleukin-33 in Serum and Carcinoma Tissue from Patients with Hepatocellular Carcinoma and its Clinical Implications","volume":"40","author":"Zhang","year":"2012","journal-title":"J Int Med Res"},{"issue":"2","key":"10.1016\/j.amjms.2020.06.023_bib0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/liv.13503","article-title":"DAMP Molecular IL-33 Augments Monocytic Inflammatory Storm in Hepatitis B-Precipitated Acute-on-Chronic Liver Failure","volume":"38","author":"Du","year":"2018","journal-title":"Liver Int"},{"issue":"11","key":"10.1016\/j.amjms.2020.06.023_bib0016","doi-asserted-by":"crossref","first-page":"5666","DOI":"10.4049\/jimmunol.1300117","article-title":"IL-33 Induces Nuocytes and Modulates Liver Injury in Viral Hepatitis","volume":"190","author":"Liang","year":"2013","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.amjms.2020.06.023_bib0017","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1620\/tjem.234.255","article-title":"Interleukin-33 Promotes Disease Progression in Patients With Primary Biliary Cirrhosis","volume":"234","author":"Sun","year":"2014","journal-title":"Tohoku J Exp Med"},{"issue":"1","key":"10.1016\/j.amjms.2020.06.023_bib0018","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jhep.2011.03.022","article-title":"Protective Role of IL-33\/ST2 Axis in Con A-Induced Hepatitis","volume":"56","author":"Volarevic","year":"2012","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.amjms.2020.06.023_bib0019","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","article-title":"Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis","volume":"39","author":"McHedlidze","year":"2013","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.amjms.2020.06.023_bib0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/cmi.2016.62","article-title":"Interleukin-33 in the Pathogenesis of Liver Fibrosis: Alarming ILC2 and Hepatic Stellate Cells","volume":"14","author":"Weiskirchen","year":"2017","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"10.1016\/j.amjms.2020.06.023_bib0021","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12072-012-9365-4","article-title":"Asian-Pacific Consensus Statement on the Management of Chronic Hepatitis B: A 2012 Update","volume":"6","author":"Liaw","year":"2012","journal-title":"Hepatol Int"},{"issue":"5","key":"10.1016\/j.amjms.2020.06.023_bib0022","first-page":"363","article-title":"[Diagnostic Criteria for HBV-Related Acute-on-Chronic Pre-Liver Failure]","volume":"24","author":"Zhang","year":"2016","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"6","key":"10.1016\/j.amjms.2020.06.023_bib0023","doi-asserted-by":"crossref","first-page":"e64379","DOI":"10.1371\/journal.pone.0064379","article-title":"A modified MELD model for Chinese pre-ACLF and ACLF patients and it reveals poor prognosis in pre-ACLF patients","volume":"8","author":"Xia","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.amjms.2020.06.023_bib0024","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jvh.12612","article-title":"Patients with HBV-related acute-on-chronic liver failure have increased concentrations of extracellular histones aggravating cellular damage and systemic inflammation","volume":"24","author":"Li","year":"2017","journal-title":"J Viral Hepat"},{"issue":"2","key":"10.1016\/j.amjms.2020.06.023_bib0025","first-page":"236","article-title":"External Validation and Comparison of Six Prognostic Models in a Prospective Cohort of HBV-ACLF in China","volume":"15","author":"Shen","year":"2016","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.amjms.2020.06.023_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/630265","article-title":"Interleukin-1 Family Cytokines in Liver Diseases","volume":"2015","author":"Tsutsui","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"47","key":"10.1016\/j.amjms.2020.06.023_bib0027","doi-asserted-by":"crossref","first-page":"e1889","DOI":"10.1097\/MD.0000000000001889","article-title":"Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?","volume":"94","author":"Oztas","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.amjms.2020.06.023_bib0028","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1089\/jir.2011.0109","article-title":"Serum IL-33 Levels are Associated with Liver Damage in Patients With Chronic Hepatitis B","volume":"32","author":"Wang","year":"2012","journal-title":"J Interf Cytokine Res"},{"key":"10.1016\/j.amjms.2020.06.023_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/819636","article-title":"Serum IL-33 Levels are Associated with Liver Damage in Patients with Chronic Hepatitis C","volume":"2012","author":"Wang","year":"2012","journal-title":"Mediators Inflamm"},{"issue":"1","key":"10.1016\/j.amjms.2020.06.023_bib0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2249.2006.03259.x","article-title":"Altered Immune Function of Monocytes in Different Stages of Patients with Acute on Chronic Liver Failure","volume":"147","author":"Xing","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.amjms.2020.06.023_bib0031","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1499-3872(16)60185-6","article-title":"Serum Soluble ST2 is a Promising Prognostic Biomarker in HBV-Related Acute-on-Chronic Liver Failure","volume":"16","author":"Jiang","year":"2017","journal-title":"Hepatobiliary Pancreatic Dis Int"},{"key":"10.1016\/j.amjms.2020.06.023_bib0032","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/535938","article-title":"Soluble ST2 Plasma Concentrations Predict Mortality in HBV-Related Acute-on-Chronic Liver Failure","volume":"2015","author":"Lei","year":"2015","journal-title":"Mediators Inflamm"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962920302822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962920302822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:15:27Z","timestamp":1762082127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962920302822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0002962920302822"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2020.06.023","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Expression of Interleukin-33\/ST2 Predicts the Progression and Poor Prognosis in Chronic Hepatitis B Patients with Hepatic Flare","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2020.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc. on behalf of Southern Society for Clinical Investigation.","name":"copyright","label":"Copyright"}]}}